The National Agency for Food and Drug Administration and Control (NAFDAC) has issued a warning to Nigerians about the circulation of counterfeit Phesgo cancer treatment drugs.
The alert follows a report from a doctor at Lagos University Teaching Hospital (LUTH), who raised concerns about the authenticity of a batch of the drug.
NAFDAC informed healthcare providers of the suspected counterfeit Phesgo 600mg/600mg, labeled with batch number C5290S20.
The marketing authorization holder, Roche, was also notified of the issue after the doctor reported the drug but did not return any physical samples for investigation.
Instead, images of parts of the product, including a vial and a 10ml folding box, were shared with Roche for comparison.
NAFDAC emphasized that the counterfeit batch resembles a previously reported fraudulent batch, C3809C51, which could pose serious risks to patients.
The agency urged healthcare professionals and the public to remain vigilant and avoid administering or purchasing the affected drug until further investigation is complete.
